Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone.

Shivani Sood,Gurpreet Kaur Bhatia,Prachi Seth,Pawan Kumar,Jagjit Kaur, Vidisha Gupta,Sandeep Punia,Hardeep Singh Tuli

Current pharmacology reports（2021）

引用 13|浏览1

暂无评分

摘要

The review describes the path of favipiravir and dexamethasone from chemistry to mechanisms of action to combat SARS-CoV-2. In addition, the potential side effects are also summarized to study their potential to control corona virus 2019

查看译文

关键词

Coronavirus 2019,Dexamethasone,Epidemiology,Favipiravir,Severe acute respiratory syndrome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要